0.97 (4.97%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Weak
Earnings
Strong
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Arcutis Biotherapeutics Inc
Telephone
1.805.418.5006
Address
Suite 300, 3027 Townsgate Road, Westlake Village, CA 91361
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 12.72 - 31.77
Trade Value (12mth)
US$9,838,805.00
1 week
-8.54%
1 month
-16.67%
YTD
-32.76%
1 year
41.72%
All time high
40.88
EPS 3 yr Growth
-97.80%
EBITDA Margin
-1.80%
Operating Cashflow
-$6m
Free Cash Flow Return
-2.00%
ROIC
-5.70%
Interest Coverage
-0.60
Quick Ratio
3.00
Shares Outstanding (Fully Diluted)
129m
HALO Sector
Healthcare
Next Company Report Date
02-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 07 May 26 | |
| 07 May 26 | |
| 07 May 26 | |
| 26 February 26 | |
| 26 February 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -3.78 | -1.16 | -0.13 | | | | ||
EPS (Fully Diluted) | $ | | | | | -3.78 | -1.16 | -0.13 | | | | ||
Growth | % | | | | | 33.2 | 69.4 | 89 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
